In an effort to reach out to the American public, the US Food and Drug Administration (FDA) in December announced a collaboration with online health information provider WebMD to disseminate health and drug safety information. The deal gives the FDA pages within WebMD's website and print magazine. WebMD.com reaches a far larger audience than the FDA's website with nearly 50 million unique visitors each month compared with the FDA's 6 million. “It's important to put the information where the people are going, and not expect them to come to us,” says FDA's Jason Brodsky, director of consumer health information. The WebMD-FDA site http://www.webmd.com/fda/ links to the agency's guides to reporting adverse events and understanding product recalls, and offers safety tips on drugs, medical devices, food and cosmetics. The agency plans to add multi-media content and features on the safe use of products. For example, the agency will offer a guide to parents on vaccines, warn consumers about unlawful distribution of unapproved drugs and answer questions such as, What are biologics? European agencies are also attempting to improve online access to health information. The UK's National Health Service (NHS) plans to launch in April NHS Evidence, a web-based service that consolidates clinical data and experience, prescribing and safety information, and technology appraisals. And the European Commission in December adopted a legislative proposal aimed to improve patient access to information about drugs.